Selected research
Industry Research
Antibiotics Industry Research Report 2026
Market perspective
The global Antibiotics market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Antibiotics is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Antibiotics is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Antibiotics is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Antibiotics include Astellas Pharma, Bristol Myers Squibb Company, Janssen Pharmaceuticals, Bayer, GlaxoSmithKline, Pfizer, Eli Lilly and Company, Novartis and Sanofi, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Antibiotics market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Antibiotics Market by Company
Astellas Pharma
Bristol Myers Squibb Company
Janssen Pharmaceuticals
Bayer
GlaxoSmithKline
Pfizer
Eli Lilly and Company
Novartis
Sanofi
Abbott
Antibiotics Segment by Type
Cephalosporins
Macrolides
Sulfonamides
Others
Penicillins
Aminoglycosides
Tetracyclines
Antibiotics Segment by Application
Poultry
Livestock
Other
Antibiotics Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Antibiotics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Antibiotics and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Antibiotics.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Antibiotics manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Antibiotics by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Antibiotics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Cephalosporins
- Macrolides
- Sulfonamides
- Others
- Penicillins
- Aminoglycosides
- Tetracyclines
Applications
- Poultry
- Livestock
- Other
Companies covered
- Astellas Pharma
- Bristol Myers Squibb Company
- Janssen Pharmaceuticals
- Bayer
- GlaxoSmithKline
- Pfizer
- Eli Lilly and Company
- Novartis
- Sanofi
- Abbott
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Antibiotics Market Size (2021-2032)
- 2.2.2 Global Antibiotics Sales (2021-2032)
- 2.2.3 Global Antibiotics Market Average Price (2021-2032)
- 2.3 Antibiotics by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Cephalosporins
- 2.3.3 Macrolides
- 2.3.4 Sulfonamides
- 2.3.5 Others
- 2.3.6 Penicillins
- 2.3.7 Aminoglycosides
- 2.3.8 Tetracyclines
- 2.4 Antibiotics by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Poultry
- 2.4.3 Livestock
- 2.4.4 Other
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Antibiotics Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Antibiotics Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Antibiotics Revenue of Manufacturers (2021-2026)
- 3.4 Global Antibiotics Average Price by Manufacturers (2021-2026)
- 3.5 Global Antibiotics Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Antibiotics, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Antibiotics, Product Type & Application
- 3.8 Global Manufacturers of Antibiotics, Established Date
- 3.9 Global Antibiotics Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Astellas Pharma
- 4.1.1 Astellas Pharma Company Information
- 4.1.2 Astellas Pharma Business Overview
- 4.1.3 Astellas Pharma Antibiotics Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Astellas Pharma Antibiotics Product Portfolio
- 4.1.5 Astellas Pharma Recent Developments
- 4.2 Bristol Myers Squibb Company
- 4.2.1 Bristol Myers Squibb Company Company Information
- 4.2.2 Bristol Myers Squibb Company Business Overview
- 4.2.3 Bristol Myers Squibb Company Antibiotics Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Bristol Myers Squibb Company Antibiotics Product Portfolio
- 4.2.5 Bristol Myers Squibb Company Recent Developments
- 4.3 Janssen Pharmaceuticals
- 4.3.1 Janssen Pharmaceuticals Company Information
- 4.3.2 Janssen Pharmaceuticals Business Overview
- 4.3.3 Janssen Pharmaceuticals Antibiotics Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Janssen Pharmaceuticals Antibiotics Product Portfolio
- 4.3.5 Janssen Pharmaceuticals Recent Developments
- 4.4 Bayer
- 4.4.1 Bayer Company Information
- 4.4.2 Bayer Business Overview
- 4.4.3 Bayer Antibiotics Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Bayer Antibiotics Product Portfolio
- 4.4.5 Bayer Recent Developments
- 4.5 GlaxoSmithKline
- 4.5.1 GlaxoSmithKline Company Information
- 4.5.2 GlaxoSmithKline Business Overview
- 4.5.3 GlaxoSmithKline Antibiotics Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 GlaxoSmithKline Antibiotics Product Portfolio
- 4.5.5 GlaxoSmithKline Recent Developments
- 4.6 Pfizer
- 4.6.1 Pfizer Company Information
- 4.6.2 Pfizer Business Overview
- 4.6.3 Pfizer Antibiotics Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Pfizer Antibiotics Product Portfolio
- 4.6.5 Pfizer Recent Developments
- 4.7 Eli Lilly and Company
- 4.7.1 Eli Lilly and Company Company Information
- 4.7.2 Eli Lilly and Company Business Overview
- 4.7.3 Eli Lilly and Company Antibiotics Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Eli Lilly and Company Antibiotics Product Portfolio
- 4.7.5 Eli Lilly and Company Recent Developments
- 4.8 Novartis
- 4.8.1 Novartis Company Information
- 4.8.2 Novartis Business Overview
- 4.8.3 Novartis Antibiotics Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Novartis Antibiotics Product Portfolio
- 4.8.5 Novartis Recent Developments
- 4.9 Sanofi
- 4.9.1 Sanofi Company Information
- 4.9.2 Sanofi Business Overview
- 4.9.3 Sanofi Antibiotics Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Sanofi Antibiotics Product Portfolio
- 4.9.5 Sanofi Recent Developments
- 4.10 Abbott
- 4.10.1 Abbott Company Information
- 4.10.2 Abbott Business Overview
- 4.10.3 Abbott Antibiotics Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Abbott Antibiotics Product Portfolio
- 4.10.5 Abbott Recent Developments
5 Global Antibiotics Market Scenario by Region
- 5.1 Global Antibiotics Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Antibiotics Sales by Region: 2021-2032
- 5.2.1 Global Antibiotics Sales by Region: 2021-2026
- 5.2.2 Global Antibiotics Sales by Region: 2027-2032
- 5.3 Global Antibiotics Revenue by Region: 2021-2032
- 5.3.1 Global Antibiotics Revenue by Region: 2021-2026
- 5.3.2 Global Antibiotics Revenue by Region: 2027-2032
- 5.4 North America Antibiotics Market Facts & Figures by Country
- 5.4.1 North America Antibiotics Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Antibiotics Sales by Country (2021-2032)
- 5.4.3 North America Antibiotics Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Antibiotics Market Facts & Figures by Country
- 5.5.1 Europe Antibiotics Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Antibiotics Sales by Country (2021-2032)
- 5.5.3 Europe Antibiotics Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.6 Asia Pacific Antibiotics Market Facts & Figures by Country
- 5.6.1 Asia Pacific Antibiotics Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Antibiotics Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Antibiotics Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Antibiotics Market Facts & Figures by Country
- 5.7.1 South America Antibiotics Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Antibiotics Sales by Country (2021-2032)
- 5.7.3 South America Antibiotics Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.7.7 Colombia
- 5.8 Middle East and Africa Antibiotics Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Antibiotics Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Antibiotics Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Antibiotics Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global Antibiotics Sales by Type (2021-2032)
- 6.1.1 Global Antibiotics Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Antibiotics Sales Market Share by Type (2021-2032)
- 6.2 Global Antibiotics Revenue by Type (2021-2032)
- 6.2.1 Global Antibiotics Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Antibiotics Revenue Market Share by Type (2021-2032)
- 6.3 Global Antibiotics Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Antibiotics Sales by Application (2021-2032)
- 7.1.1 Global Antibiotics Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Antibiotics Sales Market Share by Application (2021-2032)
- 7.2 Global Antibiotics Revenue by Application (2021-2032)
- 7.2.1 Global Antibiotics Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Antibiotics Revenue Market Share by Application (2021-2032)
- 7.3 Global Antibiotics Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Antibiotics Value Chain Analysis
- 8.1.1 Antibiotics Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Antibiotics Production Mode & Process
- 8.2 Antibiotics Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Antibiotics Distributors
- 8.2.3 Antibiotics Customers
9 Global Antibiotics Analyzing Market Dynamics
- 9.1 Antibiotics Industry Trends
- 9.2 Antibiotics Industry Drivers
- 9.3 Antibiotics Industry Opportunities and Challenges
- 9.4 Antibiotics Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst